These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 1080122)

  • 1. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.
    de Moura MC; Vernace SJ; Paronetto F
    Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
    Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
    Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infection due to hepatitis B virus and host immune response].
    Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to HBcAg and HBsAg in patients with chronic hepatitis.
    Scaroni C; Cancellieri V; Vernace S; Paronetto F
    J Clin Lab Immunol; 1981 Jul; 6(1):45-50. PubMed ID: 7265174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Test of leukocyte migration in agarose (LMAT) in HBs positive and negative chronic hepatopathies in the presence of an HBsAg preparation].
    Craxi A; Genova G; Spano C; Chiarini A; Pagliaro L
    Minerva Gastroenterol; 1976; 22(3):253-6. PubMed ID: 1004759
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated immunity in response to HBs antigen.
    Szkaradkiewicz A; Kiczka W
    Z Immunitatsforsch Immunobiol; 1978 Sep; 154(5):463-70. PubMed ID: 726550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
    Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
    Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver-specific proteins and autoimmunity in inflammatory liver diseases].
    Alberti A; Realdi G; Bortolotti F; Trevisan A; Tremolada F; Rigoli A
    Boll Ist Sieroter Milan; 1976; 55(5):411-25. PubMed ID: 1016592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases.
    Meyer zum Büschenfelde KH; Alberti A; Arnold W; Freudenberg J
    Klin Wochenschr; 1975 Nov; 53(22):1061-7. PubMed ID: 1083922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunology of liver diseases].
    Meyer zum Büschenfelde KH
    Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity to hepatitis B surface antigen in man.
    Hanson RG; Hoofnagle JH; Minuk GY; Purcell RH; Gerin JL
    Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
    Lau DT; Hewlett AT
    Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
    J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
    Hopf U; Meyer zum Büschenfelde KH; Arnold W
    N Engl J Med; 1976 Mar; 294(11):578-82. PubMed ID: 1107836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.